Kakehasi AM, Radominski SC, Baravalle MD, Palazuelos FCI, et al. Safety of upadacitinib in Latin American patients with rheumatoid arthritis: an integrated safety analysis of the SELECT phase 3 clinical program. Clin Rheumatol 2023 Jan 30:1-10. doi: 10.1007/s10067-023-06513.
PMID: 36715850